EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE

Their core work

EIWH is an Ireland-based advocacy and research organization focused on sex- and gender-specific health issues affecting women across the lifespan. They contribute health policy expertise, patient engagement strategies, and gender-equity perspectives to large European health research consortia. Their work spans from Alzheimer's disease patient engagement to cervical cancer screening equity and reproductive health conditions like PCOS, consistently bringing a women's health lens to multi-partner clinical and public health projects.

What they specialise in

How they've shifted over time

In the early period (2016–2018), EIWH worked on broader topics: citizen engagement, responsible innovation governance, and patient engagement in Alzheimer's research — acting as a general public engagement partner. From 2019 onward, they shifted sharply toward clinical women's health: pregnancy pharmacovigilance, cervical cancer screening equity, and PCOS treatment in young women. This evolution shows a clear move from general engagement and governance roles toward deep specialization in gender-specific health research.

EIWH is consolidating around women's health equity and implementation science — expect future involvement in gender-sensitive clinical trials, maternal health, and health screening access projects.

How they like to work

EIWH always participates as a partner, never as coordinator, typically joining large consortia (116 unique partners across 5 projects). They bring a specific perspective — gender equity and women's health advocacy — rather than leading technical work packages. This makes them a reliable specialist contributor who adds a critical dimension that many health consortia need but often lack.

EIWH has built an extensive network of 116 unique partners across 27 countries through just 5 projects, reflecting their participation in very large European health consortia. Their reach is pan-European with no apparent geographic clustering.

What sets them apart

EIWH fills a niche that few organizations occupy: they are a dedicated women's health institute that bridges advocacy, policy, and clinical research within EU consortia. While many partners bring technical or clinical expertise, EIWH brings the gender-equity and patient-perspective lens that funding agencies increasingly require. For consortium builders in health, they offer credibility on sex- and gender-specific dimensions that generic public engagement partners cannot match.

Highlights from their portfolio

• CBIG-SCREEN
  Largest funded project (EUR 208,375) combining cervical cancer screening with health equity approaches for vulnerable women — directly aligned with EIWH's core mission.
• ConcePTION
  Major IMI2 initiative building a Europe-wide ecosystem for pregnancy medication safety, including biobanks and predictive models — high-impact infrastructure project.
• SPIOMET4HEALTH
  Addresses PCOS treatment guided by pathophysiology in adolescent girls, representing EIWH's deepening focus on reproductive health across the female lifespan.